CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
IRWD Ironwood Pharmaceuticals
- 0.9578
- +0.0459+5.03%
Trading May 2 13:32 ET
154.99MMarket Cap95.78P/E (TTM)
0.9785High0.9100Low999.68KVolume0.9402Open0.9119Pre Close953.69KTurnover0.81%Turnover Ratio95.78P/E (Static)161.82MShares8.230052wk High-0.51P/B118.43MFloat Cap0.591052wk Low--Dividend TTM123.65MShs Float21.2000Historical High--Div YieldTTM7.51%Amplitude0.5910Historical Low0.9530Avg Price1Lot Size
About Ironwood Pharmaceuticals Company
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Company Profile
SymbolIRWD
Company NameIronwood Pharmaceuticals
Listing DateFeb 3, 2010
Issue Price11.25
Founded1998
CEOMr. Thomas A. McCourt
MarketNASDAQ
Employees253
Fiscal Year Ends12-31
Address100 Summer Street,Suite 2300
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-617-621-7722
Company Executives
- Name
- Position
- Salary
- Thomas A. McCourt
- Director, President and Chief Executive Officer
- 6.08M
- Gregory S. Martini
- Senior Vice President and Chief Financial Officer
- --
- Tammi L. Gaskins
- Senior Vice President and Chief Commercial Officer
- --
- John Minardo
- Senior Vice President, Chief Legal Officer and Secretary
- 2.70M
- Dr. Michael Shetzline, M.D.,PhD
- Senior Vice President, Chief Medical Officer and Head of Research and Drug Development
- 2.74M
- Ronald Silver, C.P.A.
- Principal Accounting Officer, Senior Vice President and Corporate Controller
- --
- Julie H. McHugh
- Chairman of the Board
- 239.57K
- Marla L. Kessler
- Independent Director
- 198.57K
- Catherine Moukheibir
- Independent Director
- 213.57K
- Jon R. Duane
- Independent Director
- 203.57K
- Jay P. Shepard
- Independent Director
- 199.57K
- Andrew Dreyfus
- Independent Director
- 208.57K
- Dr. Mark G. Currie,PhD
- Independent Director
- 198.57K
- Dr. Alexander J. Denner, PhD
- Independent Director
- 198.56K
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call